Navigation Links
ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine

IRVINE, Calif., May 08, 2007 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc., today announced results from the preliminary analysis of its U.S. Phase II/III clinical study of bepotastine for the treatment of allergic conjunctivitis. The study evaluated two concentrations of bepotastine, each dosed once daily and twice daily. The primary endpoints of the study were the assessment of efficacy for bepotastine in treating ocular itching and redness. The preliminary results of the study demonstrate both concentrations were highly statistically significant in the reduction of the first primary endpoint, ocular itching, when dosed twice a day, and in one concentration when dosed once a day. In addition, both concentrations and dosing regimens produced highly statistically significant differences in the rapidity of response and the improvement in total nasal symptoms vs. placebo. In the preliminary evaluation of the second primary endpoint, ocular redness, bepotastine showed a trend toward clinical significance, but did not achieve statistical significance. Several ocular allergy products have been approved by the FDA based on Phase III clinical data demonstrating the achievement of statistical significance and clinical success for one of the primary endpoints, ocular itching or redness.

ISTA plans to complete the Phase II/III study analysis and then discuss the results with the Food and Drug Administration to determine the remaining clinical studies required to confirm ocular safety and efficacy for the submission of an NDA for bepotastine for the treatment of allergic conjunctivitis.

"Bepotastine's multiple mechanisms of action have the potential to provide allergy sufferers with comprehensive protection for the treatment of their ophthalmic and nasal symptoms. We are impressed with the convenient dosing schedule, the rapid onset of action, and clinical efficacy bepotastine exhibited in this study,
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:9/22/2014)... , Sept. 22, 2014 The western ... stage. It is largely a replacement market with ... The mergers, acquisitions and partnerships are redefining competitive ... This research service provides details about revenue forecasts, ... pricing trends across the country. The changing landscape ...
(Date:9/22/2014)... A study on the global ... to Transparency Market Research,s database of market reports. Titled ... Share & Forecast (2011 - 2017)", the report indicates ... billion in 2011, would observe growth at a CAGR ... the report), and end-up valuing US$ 4.8 billion by ...
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014  Continua ... leader in healthcare technology, media and telecommunications,  have ... in China and promote ... and BHG announced this new partnership during the ... in Washington, DC , while ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 2Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 4Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... N.J., Oct. 10, 2011 The New Jersey Patient Care ... the Garden State, encourages men and their families to speak ... Preventive Services Task Force (USPSTF) recommended healthy men should no ... routine cancer screening. This decision was made ...
... 10, 2011 IRIDEX Corporation (Nasdaq: IRIX ) ... President and Chief Executive Officer effective today. Dr. Beck replaces ... Chief Technology Officer, and will also replace Mr. Boutacoff on ... has spent the majority of his career in leadership and ...
Cached Medicine Technology:NJ Docs Say Cancer Detection Tool Saves Lives 2IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO 2IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO 3IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO 4
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- All sexually ... the most common sexually transmitted infections: chlamydia and ... Preventive Services Task Force. The task ... younger than 24 years of age and pregnant ... don,t develop noticeable symptoms. As a result, many ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Transvaginal ... Scientific Corp. continue to move forward in the ... Court, Southern District of West Virginia, Bernstein Liebhard ... Docket Control Order was issued by the Court ... matters pertaining to the upcoming trial for consolidated ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Alan Mozes HealthDay ... Pediatricians, take note: Many American parents are aware of online ... choose a pediatrician for their children, according to a new ... more than 1,600 parents -- further suggest that negative online ... that doctor has been recommended by a neighbor. Conversely, ...
(Date:9/22/2014)... transplant seems futuristic, if not impossible. But with ... Defense, researchers at University of California, San Diego ... of an entire, functional eye a reality. , ... grail for vision restoration," said Jeffrey Goldberg, MD, ... colleagues at University of Pittsburg Medical Center and ...
Breaking Medicine News(10 mins):Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Looking ahead: Whole eye transplant under development 2
... unexpectedly wetter than earlier believed, a new study carried ... said. ,According to the satellite-based research ... have risen, but precipitation has also kept pace. ... of climate models to accurately predict precipitation on regional ...
... in Hong Kong have identified a protein in human sperm ... infertility . ,As part of the study, researchers examined ... They found that the sperms of mutant mice had very ... ,'(The protein) is involved in the transport of bicarbonate, ...
... show highlighting the need for more organ donors, or a ... of controversy, a Dutch channel Friday was to air a ... ,The controversy stirred by "The Big DonorShow" has ... broadcaster BNN is determined to go ahead. ,While ...
... dollars spent on national security in airports, a man infected ... travel unhindered into the United States, underscoring how drug-resistant strains ... against the U.S. ,The attention this story has been ... it's just a glimpse of the potential nightmare ahead. ...
... who spent 19 years in a coma has woken up and will ... longer in power, a television station announced Friday. ,Railwayman ... train in 1988, the private channel Polsat said. In an interview, Grzebski ... ,"She's the one who always took care of me. She saved my ...
... court procedure and family disputes regarding the latest woman in ... health , say his close friends and well-wishers. ... a close friend told IANS. ,The actor is ... state of acute pain. ,'Two of the bones ...
Cached Medicine News:Health News:World may Get Much Wetter With Global Warming Than Believed 2Health News:Shock TV Reality Organ Donor Show Goes on Air 2Health News:Shock TV Reality Organ Donor Show Goes on Air 3Health News:New Strains of TB Can Be Used as a Powerful Bioterror Weapon 2Health News:New Strains of TB Can Be Used as a Powerful Bioterror Weapon 3Health News:Stress-Related Health Problems Haunts Sanjay Dutt 2
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
... Trio The pinnacle in ... diode-pumped solid-state (DPSS) 532 Photocoagulator ... (SLT) and offering maximum flexibility ... first and only Nd:YAG, Photocoagulator ...
... Delivery System is an advanced guiding ... of permanent leads during CRT implantation ... System is made from PEBAX and ... plus high radial strength to resist ...
Medicine Products: